MaxMist Instructional video
Intranasal Anesthesia — Simplified for ENT Clinics
ENT practices have historically relied on in-clinic compounding of lidocaine and vasoconstrictor sprays to anesthetize the nasal cavity before procedures. That process often requires clinics to source anesthetic ingredients and delivery components on their own, prepare products using aseptic technique, and manage changing regulatory and compliance expectations around in-office compounding.
The result is a workflow that can be time-consuming, difficult to standardize, and increasingly burdensome to maintain across clinics.
MaxMist provides a single-use, disposable intranasal anesthetic designed for ENT workflow. Manufactured in a 503B outsourcing facility, MaxMist offers a ready-to-use alternative that can help clinics simplify workflow, reduce handling steps, and move toward a more standardized, compliant process.
Designed for ENT Workflow
MaxMist supports nasal anesthesia for common ENT procedures such as:
• Nasal endoscopy
• Nasal debridement
• Nasal packing removal
• Sinonasal examination
• Office-based nasal procedures
With a disposable delivery device, clinicians can administer anesthesia quickly while reducing preparation time.
WHy Single use?
As soon as a multi-use device enters a patient area, that device should be designated as single-use and disposed of (CDC, CMS). Tip cleaning, or swapping out a new tip, does not solve the problem.
Reusable atomizers can become internally contaminated. One-way valves do not eliminate contamination.
Multi-use containers pose serious risk and consequences to patient health.
Single-Use Intranasal Delivery
MaxMist is provided in a single-patient disposable sprayer, helping clinics:
✔ Reduce handling steps
✔ Improve workflow efficiency
✔ Provide consistent dosing
✔ Avoid reusable spray bottle preparation
Single-use delivery aligns with the broader infection-control principle of avoiding shared medication pathways in patient care areas.
Manufactured for Healthcare Systems
MaxMist is produced in a 503B outsourcing facility following cGMP manufacturing standards, allowing healthcare systems to source a consistent, ready-to-use intranasal anesthetic solution.
Many ENT practices currently prepare nasal anesthetic sprays by:
• Breaking open glass vials
• Drawing medication into syringes
• Transferring into reusable spray bottles
• Reprocessing spray devices between patients
These steps add handling, create variability, and make standardization harder across providers and locations.
MaxMist eliminates these extra preparation steps with a pre-filled, single-use nasal sprayer.
Evaluate MaxMist for Your ENT Practice
We offer evaluation units for ENT clinics interested in assessing MaxMist within their workflow.
Our team works with:
• Independent ENT practices
• Multi-clinic ENT groups
• Hospital ENT departments
• Ambulatory surgery centers
Request evaluation samples or connect with our team to learn more.
we are:
Bennett Pharmaceuticals of America is a pharmaceutical manufacturer and wholesaler committed to improving patient access to high quality medicines. We aim to establish a new, superior standard for patient comfort and care by enhancing clinicians' access to our high-quality, minimally invasive, injection-free, and non-opioid medications.
We are an FDA-registered 503B manufacturing facility producing sterile and non-sterile pharmaceutical products. As a registered 503B pharmaceutical manufacturer and wholesaler, Bennett serves doctors, hospitals, veterinarians and dentists.
This site is intended only for medical professionals.
What sets us apart:
-
Bennett Pharma is only one of seventy-four 503B Manufacturing Facilities in the United States. The goal of the law is to increase patient safety. A 503B outsourcing facility is different than a traditional compound pharmacy because it is registered with the FDA, it is inspected by the FDA, it manufactures sterile drugs, it follows cGMP (current good manufacturing practices) and all products undergo rigorous testing.
As a 503B we can:
compound any products on the bulk substance list
produce any drugs on the drug shortage list
sell for office stock (rather than single, prescriptions)
provide needed medications to the medical, dental, and veterinary industries.
-
Bennett Pharmaceuticals is committed to significantly enhancing patient comfort through our superior proprietary topical anesthetics. We aim to set a new standard of patient care in both the medical and dental industries. By forging strategic partnerships, we will revolutionize pain management and transform patient experiences across the healthcare landscape.
-
Orlicaine and STAT have formulation and method patent protection that will provide 20 years exclusivity from the date of filing of the provisional patent application. As a 503B outsourcing facility Bennett manufactures Orlicaine and STAT as products and sells directly to doctors, clinics, hospitals, dentists, GPOs and DSOs (dental service organizations) at the wholesale level.
-
Bennett Pharma is committed to producing the highest quality compounded pharmaceuticals. All batches are produced according to cGMP and tested prior to release.
-
Establish a new, superior standard for patient comfort and care by enhancing clinicians' access to our high-quality, minimally invasive, injection-free, and non-opioid medications produced in our 503B Pharmacy according to cGMP.
Contact us:
Phone: +1-612-356-2224 or 952-855-7768
Email: info@bennett-pharma.com
596 Outpost Circle, Suite B, Hudson, WI 54016
Stay connected:
